Dr. Maynard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1775 Lexington Ave
Suite 200
Cincinnati, OH 45212Phone+1 513-533-6325- Is this information wrong?
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Neurology, 1989 - 1992- Medical College of Wisconsin Affiliated HospitalsInternship, Internal Medicine, 1988 - 1989
- Medical College of WisconsinClass of 1988
Marquette UniversityB.S., 1980 - 1984
Certifications & Licensure
OH State Medical License 2008 - 2026
WI State Medical License 1989 - 2025
KY State Medical License 2006 - 2025
IN State Medical License 2014 - 2015
IL State Medical License 1995 - 2014
IA State Medical License 1999 - 2002- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Awards, Honors, & Recognition
- Compassionate Care in Neurology Award Medical College of Wisconsin, 1992
- US Navy Achievement Medal Secretary of the US Navy, 1980
Publications & Presentations
PubMed
- 7 citationsPharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects.Ofer Spiegelstein, Jasper Stevens, Joop M. A. van Gerven, Pradeep J. Nathan, James P Maynard, David Mayleben, Edward T. Hellriegel, Ronghua Yang> ;Journal of Psychopharmacology. 2016 May 24
Journal Articles
- Efavirenz modulation of sleep spindles and sleep spectral profileSimen AA, Ma J, Svetnik V, Mayleben D, Maynard J, Roth A, Mixson L, Mogg R, Shera D, George L, Mast TC, Beals C, Stoch A, Struyk A, Shire N, Fraiser L, Journal of sleep research, 1/1/2016
- Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjectsSpiegelstein O, Stevens J, Van Gerven J, Nathan PJ, Maynard JP, Mayleben DW, Hellriegel E, Yang R,, Journal of Psychopharmacology, 1/1/2016
Research History
- Lead Physician CTI/CRC2008 - Present
Hospital Affiliations
Bethesda North HospitalCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
